Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoshiyasu Karino

Correlation Between Efficacy of Daclatasvir/Asunaprevir Combination Therapy and HCV NS3/NS5A Resistance-Associated Variants Detected by the PCR-Invader Assay

Acta Hepatologica Japonica

Hepatology

2015

English

Renal Dysfunction With Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin Therapy

Acta Hepatologica Japonica

Hepatology

2012

English

Related publications

Retrospective Study of Risk Factors Associated With Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

2018

English

Deconvoluting the Composition of Low-Frequency Hepatitis C Viral Quasispecies: Comparison of Genotypes and NS3 Resistance-Associated Variants Between HCV/HIV Coinfected Hemophiliacs and HCV Monoinfected Patients in Japan

PLoS ONE

Multidisciplinary

2015

English

Hemoglobin Decrease With Iron Deficiency Induced by Daclatasvir Plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

PLoS ONE

Multidisciplinary

2016

English

The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor

English

Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir

English

Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir Plus Asunaprevir Treatment

Tohoku Journal of Experimental Medicine

English

Daclatasvir/Asunaprevir Based Direct-Acting Antiviral Therapy Ameliorate Hepatitis C Virus-Associated Cryoglobulinemic Membranoproliferative Glomerulonephritis: A Case Report

BMC Nephrology

Nephrology

2017

English

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir: TABLE 1

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2015

English

P21/Wafl/Cipl Cellular Expression in Chronic Long-Lasting Hepatitis C: Correlation With HCV Proteins (C, NS3, NS5A), Other Cell-Cycle Related Proteins and Selected Clinical Data.

Folia Histochemica et Cytobiologica

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoshiyasu Karino

Correlation Between Efficacy of Daclatasvir/Asunaprevir Combination Therapy and HCV NS3/NS5A Resistance-Associated Variants Detected by the PCR-Invader Assay

Renal Dysfunction With Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin Therapy

Related publications

Retrospective Study of Risk Factors Associated With Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir

Deconvoluting the Composition of Low-Frequency Hepatitis C Viral Quasispecies: Comparison of Genotypes and NS3 Resistance-Associated Variants Between HCV/HIV Coinfected Hemophiliacs and HCV Monoinfected Patients in Japan

Hemoglobin Decrease With Iron Deficiency Induced by Daclatasvir Plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor

Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir

Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir Plus Asunaprevir Treatment

Daclatasvir/Asunaprevir Based Direct-Acting Antiviral Therapy Ameliorate Hepatitis C Virus-Associated Cryoglobulinemic Membranoproliferative Glomerulonephritis: A Case Report

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir: TABLE 1

P21/Wafl/Cipl Cellular Expression in Chronic Long-Lasting Hepatitis C: Correlation With HCV Proteins (C, NS3, NS5A), Other Cell-Cycle Related Proteins and Selected Clinical Data.